Nucleome Therapeutics
Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision medicines for complex diseases
54 employees · est. 2019 · Oxford, United Kingdom
Mission Therapeutics is the older company (2011 vs 2019); Nucleome Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Mission Therapeutics | Nucleome Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2019 |
| Headquarters | ||
| Headquarters | Cambridge, United Kingdom | Oxford, United Kingdom |
| Employees | ||
| Employees | 34 | 54 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Grant | Series A |
| Total Funding | ||
| Total Funding | $133.80M | $45.20M |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Not tracked yet | 3D Genomics Technology, Disease Mechanism Exploration, Pipeline of Immunology Therapeutics, Target Identification and Validation |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Healthcare Researchers, Medical Professionals, Biotechnology Innovators |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Drug Development, Therapeutics, Deubiquitylating Enzymes, Small-molecule Drugs, Clinical Development, Patient Selection, Investment, Venture Capital, Series C Financing, Institutional Investors, Academic Collaborations, Research Centers, Cambridge | 3D Genomics, Precision Medicine, Drug Discovery, Gene Regulation, Inflammatory Conditions, External Collaborations, Target Discovery, Target Validation, Patient Stratification, Dark Genome, Genetic Variants, Autoimmune Disease, Lymphocytes, Biomarkers |
| Website | ||
| Website | missiontherapeutics.com | nucleome.com |
About Mission Therapeutics
Mission Therapeutics is a private, drug discovery and development company based in the United Kingdom, founded in 2011. The company is dedicated to selectively targeting deubiquitylating enzymes to address diseases with high unmet medical needs. Mission has succeeded in building a leading platform f...
About Nucleome Therapeutics
Nucleome Therapeutics, founded in 2019, is a pioneering biotechnology company based in the United Kingdom. With a focus on using 3D genomics, the company aims to revolutionize the discovery of precision medicines for complex diseases. The precision of Nucleome's technology promises to enhance drug...
We will tell you when either one moves
BounceWatch watches Mission Therapeutics and Nucleome Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Mission Therapeutics and Nucleome Therapeutics — by email.
Frequently Asked Questions
Compare Mission Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Mission Therapeutics on 12 Sep 2024, and Nucleome Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
